Company Filing History:
Years Active: 2001-2013
Title: Innovations of Johannes Maria Antonius Pol
Introduction
Johannes Maria Antonius Pol is a notable inventor based in Lelystad, Netherlands. He has made significant contributions to the field of virology, particularly in the development of infectious clones of RNA viruses and related vaccines. With a total of 2 patents, his work has implications for both diagnostics and therapeutic applications.
Latest Patents
Pol's latest patents focus on the creation of infectious clones derived from the genomes of wild-type RNA viruses. The process involves providing a host cell that is not susceptible to infection by the wild-type RNA virus, followed by the introduction of a recombinant nucleic acid based on the virus's genome. This recombinant nucleic acid can be a full-length DNA copy or an in vitro-transcribed RNA copy. The infectious clones developed through this method can be utilized in single or dual-purpose vaccines, as well as in viral vector vaccines.
Career Highlights
Throughout his career, Johannes Pol has worked with various organizations, including Stichting Dienst Landbouwkundig Onderzoek and Boehringer Ingelheim Vetmedica GmbH. His expertise in virology and vaccine development has positioned him as a key figure in his field.
Collaborations
Pol has collaborated with several professionals, including Johanna Jacoba Maria Meulenberg and Judy Norma Aletta Bos-de Ruijter. These collaborations have further enhanced his research and contributions to the scientific community.
Conclusion
Johannes Maria Antonius Pol's innovative work in the field of RNA viruses and vaccines demonstrates his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving public health through innovative solutions.